10 research outputs found

    Volunteer Programming for Environmental Education Centers

    No full text
    The Development of Volunteer Programs for Nature/Environmental Centers Nature centers and environmental education-related facilities are often understaffed and underbudgeted. One method these centers have used to keep up with the demand for their programs is to organize and promote a volunteer program, recruiting community members to supplement the paid staff. Even though the use of volunteers has increased, there is little written material available on volunteers at nature/environmental centers. A 1979 study in New York (Guzewich) showed that 70% of the centers surveyed used volunteers for jobs ranging from teaching to maintenance and clerical work. Of those centers not currently using volunteers, 79% felt a need for a volunteer program. It is assumed that if center directors believe volunteers are important to their program, it would be beneficial for them to know more about how to recruit and retain volunteers. . By collecting information through both a literature review and a questionnaire mailed to nature centers throughout the nation that have volunteer programs, recommendations regarding development of volunteer programs have been made. Suggestions on recruiting, training, motivation, retaining, and evaluating volunteers are included

    Le mandat extrajudiciaire dans un contexte transfrontière

    No full text
    info:eu-repo/semantics/publishe

    Dermatitis und Ekzemerkrankungen

    No full text

    Perianal Skin Diseases

    No full text

    10-year stroke prevention after successful carotidendarterectomy for asymptomatic stenosis (ACST-1):a multicentre randomised trial

    No full text
    Backgroun: If carotid artery narrowing remains asymptomatic (ie, has caused no recent stroke or other neurological symptoms), successful carotid endarterectomy (CEA) reduces stroke incidence for some years. We assessed the longterm effects of successful CEA. Methods Between 1993 and 2003, 3120 asymptomatic patients from 126 centres in 30 countries were allocated equally, by blinded minimised randomisation, to immediate CEA (median delay 1 month, IQR 0·3–2·5) or to indefi nite deferral of any carotid procedure, and were followed up until death or for a median among survivors of 9 years (IQR 6–11). The primary outcomes were perioperative mortality and morbidity (death or stroke within 30 days) and non-perioperative stroke. Kaplan-Meier percentages and logrank p values are from intention-to-treat analyses. This study is registered, number ISRCTN26156392. Findings 1560 patients were allocated immediate CEA versus 1560 allocated deferral of any carotid procedure. The proportions operated on while still asymptomatic were 89·7% versus 4·8% at 1 year (and 92·1% vs 16·5% at 5 years). Perioperative risk of stroke or death within 30 days was 3·0% (95% CI 2·4–3·9; 26 non-disabling strokes plus 34 disabling or fatal perioperative events in 1979 CEAs). Excluding perioperative events and non-stroke mortality, stroke risks (immediate vs deferred CEA) were 4·1% versus 10·0% at 5 years (gain 5·9%, 95% CI 4·0–7·8) and 10·8% versus 16·9% at 10 years (gain 6·1%, 2·7–9·4); ratio of stroke incidence rates 0·54, 95% CI 0·43–0·68, p<0·0001. 62 versus 104 had a disabling or fatal stroke, and 37 versus 84 others had a non-disabling stroke. Combining perioperative events and strokes, net risks were 6·9% versus 10·9% at 5 years (gain 4·1%, 2·0–6·2) and 13·4% versus 17·9% at 10 years (gain 4·6%, 1·2–7·9). Medication was similar in both groups; throughout the study, most were on antithrombotic and antihypertensive therapy. Net benefi ts were signifi cant both for those on lipid-lowering therapy and for those not, and both for men and for women up to 75 years of age at entry (although not for older patients). Interpretation Successful CEA for asymptomatic patients younger than 75 years of age reduces 10-year stroke risks. Half this reduction is in disabling or fatal strokes. Net benefit in future patients will depend on their risks from unoperated carotid lesions (which will be reduced by medication), on future surgical risks (which might differ from those in trials), and on whether life expectancy exceeds 10 years
    corecore